Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep - Chairman's EGM Address (ASX:IMM)

Ladies and Gentlemen, On behalf of the Board, I would like to welcome you to Immutep’s Extraordinary General Meeting to consider resolutions relating to the Company’s announced $60 mi...read more

Immutep - 2021 EGM Presentation (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep - Change in substantial holding (ASX:IMM)

To view the Notice of change of interests of substantial holder, download the attached PDF.

Immutep - Application for quotation of securities (ASX:IMM)

To view the Application for quotation of +securities, download the attached PDF.

Immutep - Completion of Share Purchase Plan (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) advises that its share purchase plan (“SPP”), details of which were announced to ASX on 21 J...read more

Immutep EGM - Now to be Held as an Online Virtual Meeting (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), provides an update to the Company’s Extraordinary General Meeting (EGM or Meeting) arrangements as...read more

icetana - Investor update (ASX:ICE)

To view the investor update, download the attached PDF.

icetana - Appendix 4C Cash Flow Report (ASX:ICE)

To view the Quarterly cash flow report for entities subject to Listing Rule 4.7B, download the attached PDF.

icetana - Quarterly Activities Report (ASX:ICE)

Highlights: - Quarterly revenue of $663,000, up 76% from the prior quarter. - Cash receipts of $817,000 from customers during the quarter. - Annualised recurring revenue grew 64% to $1.3m. - 1...read more

Immutep Quarterly Activities Report & Appendix 4C (ASX:IMM)

To view the report, download the attached PDF.

Immutep - US FDA & IRB approves start of ph2b head & neck cancer trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmun...read more

Immutep - Proposed issue of securities (ASX:IMM)

To view the Proposed issue of securities, download the attached PDF.

icetana - Notification of cessation of securities (ASX:ICE)

To view the Notification of cessation of +securities, download the attached PDF.

icetana - Change of Director's Interest Notice (ASX:ICE)

To view the Change of Director’s Interest Notice, download the attached PDF.

icetana - Expiry of Performance Rights (ASX:ICE)

icetana Limited (ASX: ICE “icetana” or “the Company”) advises that 450,000 Performance Rights (subject to performance conditions, expiring 18 December 2024) have lapsed in ac...read more

Viewing: 1 - 15 of 200 Previous | Next